Document Detail


Trimethoxypsoralen in vitiligo.
MedLine Citation:
PMID:  977211     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The treatment of vitiligo has been unsatisfactory. Introduction of systemic furocoumarins to treatment regimens has given very promising results. Trimethylpsoralen has been found to be more potent than 8-methoxypsoralen. In cases studied, ultraviolet irradiation of affected sites following topical application of trimethylpsoralen was found to hasten the process of repigmentation. Simultaneous treatment of underlying disease produced a quicker response followed by sustained relief.
Authors:
R Annamalai; S A Subhan; M Vasantha; M B Lal
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of dermatology     Volume:  15     ISSN:  0011-9059     ISO Abbreviation:  Int. J. Dermatol.     Publication Date:  1976 Nov 
Date Detail:
Created Date:  1977-01-03     Completed Date:  1977-01-03     Revised Date:  2006-10-30    
Medline Journal Info:
Nlm Unique ID:  0243704     Medline TA:  Int J Dermatol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  690-3     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Child
Coumarins / therapeutic use*
Female
Follow-Up Studies
Humans
Male
Methoxsalen / therapeutic use
Ointments
Phototherapy
Trioxsalen / administration & dosage,  therapeutic use*
Vitiligo / drug therapy*,  therapy
Chemical
Reg. No./Substance:
0/Coumarins; 0/Ointments; 298-81-7/Methoxsalen; 3902-71-4/Trioxsalen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Photochemotherapy (PUVA) and psoriasis: comparison of 8-MOP and 8-MOP/5-MOP.
Next Document:  Leucocyte ascorbic acid in abnormal leucocyte states.